Tomomi Shiga

ORCID: 0000-0003-2115-7536 · 3 papers in corpus · active 2018-2025

Study types

  • article 1
  • other 1
  • preprint 1

Condition tags

  • dysmenorrhea 2
  • endometriosis 2
  • adenomyosis 1
other 2025
Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial
JMIR research protocols ·doi:10.2196/66246

BACKGROUND: The treatment of endometriosis includes analgesics, hormone therapy, and surgery. Even after surgical removal of endometriotic lesions, the risk of recurrence remains high once the normal menstrual cycle resumes. Therefore, long…

preprint 2024
Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial (Preprint)
·doi:10.2196/preprints.66246

BACKGROUND The treatment of endometriosis includes analgesics, hormone therapy, and surgery. Even after surgical removal of endometriotic lesions, the risk of recurrence remains high once the normal menstrual cycle resumes. Therefore, long…

article 2018
A Case of Serous Tubal Intraepithelial Carcinoma Diagnosed by Cytology during the Operation
·doi:10.4236/ojpathology.2018.83008

We experienced a case of serous tubal intraepithelial carcinoma (STIC), which is the earliest morphologically recognizable precursor of pelvic high grade serous carcinoma, diagnosed by cytology during the operation. A 48-year-old Japanese w…